Cellular Biomedicine Group, Inc. CBMG
No live quote for CBMG yet.
Ownership
- Institutions 33.8%
- Insiders 44.7%
- Public and other holders 21.5%
Held by insiders 44.70%
Held by institutions 33.84%
Float held by institutions 61.19%
Institutions 111
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 4.51% | 878,324 | 16.14M | Dec 30, 2020 |
| Man Group PLC | 1.27% | 247,838 | 4.55M | Sep 29, 2020 |
| Candriam Luxembourg S.C.A. | 1.21% | 235,317 | 4.33M | Dec 30, 2020 |
| Hillhouse Capital Advisors Ltd. | 1.21% | 235,214 | 4.31M | Sep 29, 2020 |
| State Street Corporation | 1.17% | 228,070 | 4.18M | Sep 29, 2020 |
| Vanguard Group, Inc. (The) | 1.11% | 216,256 | 3.97M | Sep 29, 2020 |
Top mutual fund holders
No holders on record
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BELMONT TERRY | Director | Sale | Jun 14, 2015 | 0 |
| CAO WEI | Director | Sale | Feb 29, 2016 | 174,472 |
| CHAN ANDREW K | Officer | Stock Award(Grant) | Feb 18, 2021 | 0 |
| KLEIN NORMAN PAUL II | Director | Stock Award(Grant) | Feb 5, 2013 | 136,153 |
| LEUNG PAK TO | Beneficial Owner of more than 10% of a Class of Security | Sale | Dec 22, 2014 | 0 |
| LIU TONY | Chief Executive Officer | Stock Award(Grant) | Feb 18, 2021 | 0 |
